Pfizer just pulled their Exubera (inhaled insulin) from market. A horrible way to end a horrible year for them. Pfizer’s decision to pull Exubera was purely a financial one. Thus far this year… more →
HIPPOCRATechWebmaster wrote 4 months ago: This article was sent to me by my fellow blogger, Ben who suggested that this might be an interesti … more →
kurtglmft wrote 7 months ago: According to the Indianapolis Star, Pfizer Inc. is eliminating 660 jobs at it’s plant near Ter … more →
danielteper wrote 8 months ago: New York, NY based Imclone (NASDAQ:IMCL) spiked 65% in 2007 on the promise of its only drug, Erbi … more →
KHOI wrote 9 months ago: Pfizer just pulled their Exubera (inhaled insulin) from market. A horrible way to end a horrible ye … more →
Prolificus Madison wrote 9 months ago: The New York Times has an article about Alfred E. Mann, a billionaire who has a lot of money to spen … more →
Brian wrote 10 months ago: Have you seen any of the recent ads for the new prescription drugs that are available for erectile d … more →
Steve Woodruff wrote 10 months ago: The Good Stuff: BMS gets approval for new oncology drug (for breast cancer) Ixempra. Merck gets new … more →
KHOI wrote 10 months ago: Oriel Therapeutics is a lab out of Research Triangle Park, NC. They just went through third round … more →
benbeetis wrote 11 months ago: With all of the advertising I see about Exubera I felt the need to provide a comprehensive list of a … more →
Steve Woodruff wrote 11 months ago: What seemed, at first, to be a terrific marketing idea ended in disaster this week, when, in the dea … more →
jt1279 wrote 1 year ago: I know most of you must think I’m crazy to rate Pfizer a buy. My father, who works at Pfi … more →
thecreator000 wrote 1 year ago: Exubera is a rapid-acting insulin indicated for the treatment of adults with diabetes mellitus for t … more →